These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8869295

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR, Capetillo-Zarate E, Schultz C, Rüb U, Saido TC, Yamaguchi H, Haass C, Griffin WS, Del Tredici K, Braak H, Ghebremedhin E.
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment.
    de Koning EJ, Fleming KA, Gray DW, Clark A.
    J Pathol; 1995 Feb; 175(2):253-8. PubMed ID: 7738722
    [Abstract] [Full Text] [Related]

  • 6. Association of apolipoprotein E with murine amyloid A protein amyloid.
    Kindy MS, King AR, Perry G, de Beer MC, de Beer FC.
    Lab Invest; 1995 Oct; 73(4):469-75. PubMed ID: 7474917
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients.
    Gómez-Ramos P, Mufson EJ, Morán MA.
    Microsc Res Tech; 2001 Oct 01; 55(1):48-58. PubMed ID: 11596149
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J, Walker LC, Schroeder E, Vogelgesang S, Stausske D, Walther R, Warzok RW.
    Acta Neuropathol; 2003 Jan 01; 105(1):25-9. PubMed ID: 12471457
    [Abstract] [Full Text] [Related]

  • 13. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S, Abraham CR, Zannis VI.
    Biochemistry; 1997 Aug 26; 36(34):10571-80. PubMed ID: 9265639
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
    Dolev I, Michaelson DM.
    Proc Natl Acad Sci U S A; 2004 Sep 21; 101(38):13909-14. PubMed ID: 15365176
    [Abstract] [Full Text] [Related]

  • 17. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
    Fagan AM, Holtzman DM.
    Microsc Res Tech; 2000 Aug 15; 50(4):297-304. PubMed ID: 10936884
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.